doi: 10.1161/01.CIR.0000139339.85840.DD
Over the last 10 years, prescribing GLP-1RAs has become increasingly prevalent due to their significant impact on diabetes disease control, weight loss, and cardiovascular disease risk reduction
Safety Profile and Side Effects Reported in the Trial The most common adverse effects were gastrointestinal particularly nausea, vomiting, and diarrhoea occurring most frequently during dose escalation and generally mild to moderate in severity
Bariatric surgery is often considered by individuals seeking larger long-term weight reduction or who have struggled with multiple previous weight loss approaches
Never store peptide vials on a windowsill or under direct lighting
Dehydration can worsen fatigue, dizziness, constipation, and weakness